DE FALCO, FILOMENA
 Distribuzione geografica
Continente #
EU - Europa 528
NA - Nord America 507
AS - Asia 188
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.230
Nazione #
US - Stati Uniti d'America 506
IT - Italia 194
IE - Irlanda 148
HK - Hong Kong 68
SG - Singapore 44
SE - Svezia 36
RO - Romania 34
CN - Cina 30
UA - Ucraina 25
VN - Vietnam 24
DE - Germania 21
FI - Finlandia 18
RU - Federazione Russa 14
KR - Corea 10
BE - Belgio 9
CZ - Repubblica Ceca 8
TR - Turchia 8
GB - Regno Unito 6
CI - Costa d'Avorio 5
FR - Francia 4
AT - Austria 3
CH - Svizzera 3
NL - Olanda 3
IN - India 2
BR - Brasile 1
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
KH - Cambogia 1
Totale 1.230
Città #
Chandler 158
Dublin 148
Perugia 95
Hong Kong 68
San Mateo 57
Bucharest 33
Singapore 30
Altamura 26
Dong Ket 24
Wilmington 17
New York 16
Ann Arbor 15
Lawrence 15
Medford 15
Princeton 15
Helsinki 12
Beijing 10
Jacksonville 10
Seoul 10
Andover 9
Assisi 9
Brussels 9
Boardman 8
Falls Church 8
Izmir 8
Los Angeles 8
Foligno 6
Abidjan 5
Dearborn 5
Bastia 4
Brno 4
Collazzone 4
Munich 4
Olomouc 4
Rome 4
Ashburn 3
San Paolo di Civitate 3
Vienna 3
Amsterdam 2
Ancona 2
Bhubaneswar 2
Bologna 2
Guangzhou 2
Hanover 2
Macerata 2
Melissa 2
Mirano 2
Moscow 2
Norwalk 2
Saint Petersburg 2
Shanghai 2
Syracuse 2
West Jordan 2
Baotou 1
Belovo 1
Cambridge 1
Catania 1
Civitanova Marche 1
Copenhagen 1
Den Haag 1
Fairfield 1
Frankfurt Am Main 1
Lappeenranta 1
Madrid 1
Montréal 1
Nanjing 1
Paris 1
Porto Torres 1
Quattro Castella 1
Rio Grande 1
Sector 6 1
Selargius 1
Spello 1
Tokyo 1
Woodbridge 1
Totale 934
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 126
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 114
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 77
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 75
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 69
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 67
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 67
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 66
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 61
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 60
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 56
Cocaine Addiction Treatment and Home Remedies: Use of the Scopolamine Transdermal Patch 53
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 53
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 50
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 45
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 38
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 36
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 33
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 27
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 26
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 26
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 21
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 17
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 15
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 11
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 10
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 9
Totale 1.308
Categoria #
all - tutte 6.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 1 0 3 1 2 5 3 3 11 29 2 2
2020/202191 1 3 3 4 24 7 4 2 6 3 5 29
2021/2022272 14 55 3 7 9 6 4 35 12 35 37 55
2022/2023456 17 75 0 62 50 31 11 25 160 0 19 6
2023/2024275 11 33 12 18 0 14 79 4 17 13 31 43
2024/202528 28 0 0 0 0 0 0 0 0 0 0 0
Totale 1.308